|
Status |
Public on May 28, 2020 |
Title |
Ps41 |
Sample type |
genomic |
|
|
Source name |
Psoriasis 41
|
Organism |
Homo sapiens |
Characteristics |
gender: Female tissue: peripheral blood disease state: psoriasis response: ER age: 39 age at initiation: 30 biological drug: Infliximab
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted from peripheral blood samples using the MagNa Pure® System (Roche Applied Science)
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using Illumina iScanSQ platform
|
Description |
psoriasis peripheral blood sample
|
Data processing |
GenomeStudio Methylation Software Module (v 1.9.0, Illumina). Unmethylated and methylated signal intensities in supplementary file
|
|
|
Submission date |
May 27, 2020 |
Last update date |
May 28, 2020 |
Contact name |
María C Ovejero-Benito |
Organization name |
Instituto de Investigación Sanitaria la Princesa (IIS-IP)
|
Street address |
C DIEGO DE LEÓN 62
|
City |
MADRID |
State/province |
MADRID |
ZIP/Postal code |
E28006 |
Country |
Spain |
|
|
Platform ID |
GPL13534 |
Series (1) |
GSE151278 |
Genome-wide DNA methylation analysis of peripheral blood samples of moderate-to-severe psoriasis patients treated with anti-TNF drugs |
|